Telix Pharmaceuticals (TLX) Inventory Average (2024 - 2026)
Telix Pharmaceuticals (TLX) posted quarterly Inventory Average of $31.0 million for Q4 2025, up 71.28% year-over-year from $18.1 million in Q4 2024, and up 71.28% quarter-over-quarter from $18.1 million in Q4 2024.
Powered by 
Analysis
Telix Pharmaceuticals (TLX) Inventory Average (2024 - 2026) Analysis & Trends
Telix Pharmaceuticals (TLX) has reported Inventory Average for 2 consecutive years, with $31.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Inventory Average rose 71.28% year-over-year to $31.0 million; the TTM figure through Dec 2025 stood at $31.0 million (up 71.28% YoY), while the FY2025 annual figure was $30.4 million, up 66.95% from the prior year.
- Inventory Average advanced to $31.0 million in Q4 2025 per TLX's latest filing, from $18.1 million in the prior quarter.
- Across five years, Inventory Average topped out at $31.0 million in Q4 2025 and bottomed at $18.1 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | 213.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 707.10 Mn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Telix Pharmaceuticals | 4.03 Bn | 3.74 Bn | - | 38.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.05 Mn |
| Dec 31, 2025 | 31.01 Mn |
| Dec 31, 2024 | 18.11 Mn |